Chemotherapy in Small Bowel Adenocarcinoma: 10-year Experience of the British Columbia Cancer Agency

Clinical Oncology

Volumn 19, Issue 2, 2007, Pages 143-149

  Czaykowski, P ^a   Hui, D ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Adenocarcinoma; chemotherapy; prognostic factors; second malignancies; small bowel neoplasm; therapy

Indexed keywords

CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; MITOMYCIN C; RALTITREXED;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; EXPERIENCE; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CANCER; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRITISH COLUMBIA; FEMALE; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33846698571     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.12.001     Document Type: Article

References (23)

1. Stang A., Stegmaier C., Eisinger B., et al. Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience. Br J Cancer 80 (1999) 1440-1444
2. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. CA Cancer J Clin 52 (2002) 23-47
3. Howe J.R., Karnell L.H., Menck H.R., et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 86 (1999) 2693-2706
4. North J.H., and Pack M.S. Malignant tumors of the small intestine: a review of 144 cases. Am Surg 66 (2000) 46-51
5. Contant C.M., Damhuis R.A., van Geel A.N., et al. Prognostic value of the TNM-classification for small bowel cancer. Hepatogastroenterology 44 (1997) 430-434
6. Ito H., Perez A., Brooks D.C., et al. Surgical treatment of small bowel cancer: a 20-year single institution experience. J Gastrointest Surg 7 (2003) 925-930
7. Dabaja B.S., Suki D., Pro B., et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101 (2004) 518-526
8. Bettini A.C., Beretta G.D., Sironi P., et al. Chemotherapy in small bowel adenocarcinoma associated with celiac disease: a report of three cases. Tumori 89 (2003) 193-195
9. Crawley C., Ross P., Norman A., et al. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 78 (1998) 508-510
10. Polyzos A., Kouraklis G., Giannopoulos A., et al. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 15 (2003) 503-506
11. Coia L., Hoffman J., Scher R., et al. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 30 (1994) 161-167
12. Jigyasu D., Bedikian A.Y., and Stroehlein J.R. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 53 (1984) 23-25
13. Gibson M.K., Holcroft C.A., Kvols L.K., et al. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 10 (2005) 132-137
14. Fishman P.N., Pond G.R., Moore M.J., et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 29 (2006) 225-231
15. Ripley D., and Weinerman B.H. Increased incidence of second malignancies associated with small bowel adenocarcinoma. Can J Gastroenterol 11 (1997) 65-68
16. Scelo G., Boffetta P., Hemminki K., et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 118 (2006) 189-196
17. Neugut A.I., Jacobson J.S., Suh S., et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 7 (1998) 243-251
18. Blaker H., von Herbay A., Penzel R., et al. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 21 (2002) 158-164
19. Svrcek M., Jourdan F., Sebbagh N., et al. Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study. J Clin Pathol 56 (2003) 898-903
20. Wheeler J.M., Warren B.F., Mortensen N.J., et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50 (2002) 218-223
21. Arber N., Hibshoosh H., Yasui W., et al. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 8 (1999) 1101-1105
22. Brueckl W.M., Heinze E., Milsmann C., et al. Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine. Cancer Lett 203 (2004) 181-190
23. Planck M., Ericson K., Piotrowska Z., et al. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 97 (2003) 1551-1557